TITLE

iPSCs in Drug Discovery

AUTHOR(S)
Peluso, Carolyn
PUB. DATE
July 2012
SOURCE
Drug Discovery & Development;Jul/Aug2012, Vol. 15 Issue 7, p10
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the significant role played by induced pluripotent stem cells (iPSCs) derived from adult somatic cells in drug discovery.
ACCESSION #
79449139

 

Related Articles

  • Induced pluripotent stem cells in the study of neurological diseases. Saporta, Mario A.; Grskovic, Marica; Dimos, John T. // Stem Cell Research & Therapy;2011, Vol. 2 Issue 5, p1 

    Five years after their initial derivation from mouse somatic cells, induced pluripotent stem (iPS) cells are an important tool for the study of neurological diseases. By offering an unlimited source of patient specific disease-relevant neuronal and glial cells, iPS cell-based disease models hold...

  • Notch inhibition allows oncogene-independent generation of iPS cells. Ichida, Justin K; T C W, Julia; Williams, Luis A; Carter, Ava C; Shi, Yingxiao; Moura, Marcelo T; Ziller, Michael; Singh, Sean; Amabile, Giovanni; Bock, Christoph; Umezawa, Akihiro; Rubin, Lee L; Bradner, James E; Akutsu, Hidenori; Meissner, Alexander; Eggan, Kevin // Nature Chemical Biology;Aug2014, Vol. 10 Issue 8, p632 

    The reprogramming of somatic cells to pluripotency using defined transcription factors holds great promise for biomedicine. However, human reprogramming remains inefficient and relies either on the use of the potentially dangerous oncogenes KLF4 and CMYC or the genetic inhibition of the tumor...

  • Induced pluripotent stem cells in research and therapy. Hoon-Koon Teoh; Soon-Keng Cheong // Malaysian Journal of Pathology;Jun2012, Vol. 34 Issue 1, p1 

    Induced pluripotent stem cells (iPSC) are derived from human somatic cells through ectopic expression of transcription factors. This landmark discovery has been considered as a major development towards patient-specific iPSC for various biomedical applications. Unlimited self renewal capacity,...

  • Stem cells: Sweetening pluripotency. Donner, Amy // Nature Chemical Biology;Jul2012, Vol. 8 Issue 7, p602 

    The article offers information on the transformation of somatic cells into induced pluripotent stem cells by the combination of transcription factors which includes octamer binding transcription factor 4 (OCT-4) and SOX2.

  • Stem cells: Efficient reprogramming from a privileged cell state.  // Nature Methods;Apr2014, Vol. 11 Issue 4, p369 

    The article discusses a research conducted by S. Guo, related to the identification of mouse granulocyte-monocyte progenitors and embryonic fibroblasts for reprogramming of somatic cells to induced pluripotency, published in a 2014 issue of the periodical "Cell."

  • Discovery Pipeline. Ritter, Amy // BioPharm International;Dec2012, Vol. 25 Issue 12, p7 

    The article offers information on the study that was published in the November 21, 2012 issue of "Cell" journal, regarding the mechanisms in the reprogramming of somatic cells into induced pluripotent stem cells (IPSCs) which are used for disease modeling.

  • Dynamic Changes in Occupancy of Histone Variant H2A.Z during Induced Somatic Cell Reprogramming. Dong, Fulu; Song, Zhenwei; Yu, Jiali; Zhang, Baole; Jiang, BaoChun; Shen, Ying; Lu, Youde; Song, Chunlei; Cong, Peiqing; Liu, Honglin // Sequencing;12/13/2015, p1 

    The development of induced pluripotent stem cells (iPSCs) has enabled study of the mechanisms underlying cellular reprogramming. Here, we have studied the dynamic distribution of H2A.Z during induced reprogramming with chromatin immunoprecipitation deep sequencing (ChIP-Seq). We found that H2A.Z...

  • Generation of iPSCs by Nonintegrative RNA-Based Reprogramming Techniques: Benefits of Self-Replicating RNA versus Synthetic mRNA. Steinle, Heidrun; Weber, Marbod; Behring, Andreas; Mau-Holzmann, Ulrike; Schlensak, Christian; Wendel, Hans Peter; Avci-Adali, Meltem // Stem Cells International;6/19/2019, p1 

    The reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is gaining in importance in the fields of regenerative medicine, tissue engineering, and disease modeling. Patient-specific iPSCs have as an unlimited cell source a tremendous potential for generating various types of...

  • Genetic correction of β-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice. Wang, Yixuan; Zheng, Chen-Guang; Jiang, Yonghua; Zhang, Jiqin; Chen, Jiayu; Yao, Chao; Zhao, Qingguo; Liu, Sheng; Chen, Ke; Du, Juan; Yang, Ze; Gao, Shaorong // Cell Research;Apr2012, Vol. 22 Issue 4, p637 

    The generation of induced pluripotent stem cells (iPSCs) from differentiated somatic cells by over-expression of several transcription factors has the potential to cure many genetic and degenerative diseases currently recalcitrant to traditional clinical approaches. One such genetic disease is...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics